The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of TOP2A and TIMP-1 as predictive markers of pathologic complete response to neoadjuvant anthracycline-based chemotherapy.
Joyce Maria L. Maia
No relevant relationships to disclose
Elizabeth Santana Santos
No relevant relationships to disclose
Rafael Costa Lessa
No relevant relationships to disclose
Felipe D'Almeida Costa
No relevant relationships to disclose
Stephania Bezerra
No relevant relationships to disclose
Rafael Malagoli Rocha
No relevant relationships to disclose
Carlos Frederico Lopes Benevides
No relevant relationships to disclose
Vladmir C. Lima
No relevant relationships to disclose
Adriana Regina G. Ribeiro
No relevant relationships to disclose
Marcello Ferretti Fanelli
No relevant relationships to disclose
Alexandre Andre Balieiro Anastacio da Costa
No relevant relationships to disclose
Celso Abdon Mello
No relevant relationships to disclose